Gennadiy Vengerovich

Gennadiy Vengerovich practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Gennadiy Vengerovich's NPI, 1477708907, was assigned on November 25, 2008. Gennadiy Vengerovich graduated from SUNY Downstate Health Sciences University in 2006. Gennadiy Vengerovich's New York license number on file is ME116592.

Gennadiy Vengerovich's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Gennadiy Vengerovich's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Gennadiy Vengerovich is also affiliated with Boca Raton Regional Hospital. The medical group on file is South Florida ENT Associates. Dmand AI also links Gennadiy Vengerovich to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gennadiy Vengerovich practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Gennadiy Vengerovich's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Gennadiy Vengerovich is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Gennadiy Vengerovich's licenses on file in 3 states: New York, Florida and California.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Gennadiy Vengerovich treats.

CMS data shows 2,767 Medicare services from Gennadiy Vengerovich across 21 procedure codes in 2024, for 736 Medicare patients. Medicare paid $201,128 for them.

CMS counts 736 Medicare patients who saw Gennadiy Vengerovich in 2024. The largest group is 75 to 84, with 318 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Gennadiy Vengerovich's median patient age at 58, with 56% women.

In 2024, Gennadiy Vengerovich wrote 766 Medicare Part D claims for 391 patients. 97% of them were for generic drugs. CMS names the drug for 685 of them, across 15 drugs with 11 or more claims each, at $13,089 in total drug cost. In 2023, CMS named 467 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Gennadiy Vengerovich for performance year 2024, reported individually. Gennadiy Vengerovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gennadiy Vengerovich as offering telehealth.

Dmand AI links 5 papers to Gennadiy Vengerovich, published from 2020 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents. Gennadiy Vengerovich has published most often in Otolaryngol Head Neck Surg. Gennadiy Vengerovich's most frequent co-authors are Alfredo Samuel Archilla, MD, Nima Khosravani, MD and Jivianne Kristine Tan Lee, MD.

CMS Open Payments shows 42 general payments to Gennadiy Vengerovich from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 89% of the total. Aerin Medical Inc. paid the most, $2,208.

Gennadiy Vengerovich graduated from SUNY Downstate Health Sciences University in 2006.

Gennadiy Vengerovich is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.